Gibel's announcement on convening the performance briefing for 2025 and the first quarter of 2026
Securities code: 688566 Securities abbreviation: Gibel Announcement number: 2026-014
Jiangsu Jibel Pharmaceutical Co., Ltd.
About the convening of the year and the first quarter of the year
2025 2026
Announcement of performance briefing
The company's board of directors and all directors guarantee that the announcement does not contain any false records, misleading statements or major omissions, and assume legal responsibility for the authenticity, accuracy and completeness of its contents in accordance with the law.
Important content reminder:
Conference online communication time: June 1, 2026 (Monday) 15:00-16:00
Meeting method: online text interaction
Online text interactive platform: East Fortune Roadshow Platform (Website: http://roadshow.eastmoney.com/luyan/5278320)
Investors can provide the company with issues they need to know and pay attention to in advance by email, phone, etc. before 16:00 on May 29, 2026 (Friday). The company will answer questions of common concern to investors during the interactive text session.
Jiangsu Jibel Pharmaceutical Co., Ltd. (hereinafter referred to as the "Company") has released the "Company's 2025 Annual Report" and "The Company's 2026 First Quarter Report" on the website of the Shanghai Stock Exchange (www.sse.com.cn) on April 28, 2026. In order to facilitate investors to have a more comprehensive and in-depth understanding of the company's operating results, financial status, and development philosophy, the company plans to release the "Company's 2025 Annual Report" and "The Company's 2026 First Quarter Report" on the Shanghai Stock Exchange website (www.sse.com.cn) on June 1, 2026 (Monday) at 15:00- The performance briefing for 2025 and the first quarter of 2026 will be held at 16:00 to communicate on issues of concern to investors.
1. Type of briefing session
This investor briefing will be held in the form of online interactive text, to interact and communicate with investors on the company's operating results and financial indicators for 2025 and the first quarter of 2026, and to answer questions of common concern to investors within the scope permitted by information disclosure.
2. Time and place of the briefing meeting
(1) Meeting online communication time: June 1, 2026 (Monday) 15:00-16:00
(2) Meeting method: online text interaction
(3) Online text interactive platform: Oriental Fortune Roadshow Platform (Website: http://roadshow.eastmoney.com/luyan/5278320)
(4) Investors can provide the company with issues they need to know and pay attention to in advance by email, phone, etc. before 16:00 on May 29, 2026 (Friday). The company will answer questions of common concern to investors during the interactive text session.
3. Participants
Company personnel attending this briefing include: Chairman and General Manager Mr. Geng Zhongyi, Secretary of the Board of Directors Mr. Zhai Jianzhong, Financial Director Mr. Zhao Suofu, and Independent Director Mr. Chen Liuping (if there are special circumstances, the number of participants may be adjusted).
4. Contact person and consultation method
Contact department: Securities Investment Department of the Company
Contact number: 0511-88898101-8081
Email: [email protected]
5. Other matters
After the investor briefing is held, investors can check the status and main content of the investor briefing through the East Money Roadshow Platform (website: https://roadshow.eastmoney.com/).
Announcement is hereby made.
Board of Directors of Jiangsu Jibel Pharmaceutical Co., Ltd.
May 23, 2026